A mathematical model of the impact of present and future malaria vaccines

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Wenger, Edward A ^a   Eckhoff, Philip A ^a  

^a Intellectual Ventures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSECTICIDE; MALARIA VACCINE;

ANOPHELES; ARTICLE; BED NET; CHILD; COMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; ECOLOGY; EMOD MODEL; HEALTH PROGRAM; HOST PARASITE INTERACTION; HUMAN; IMMUNIZATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; NEWBORN; PARASITE PREVALENCE; PARASITE VECTOR; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RISK REDUCTION; SCHOOL CHILD; TREND STUDY;

ADOLESCENT; ANIMALS; CHILD; CHILD, PRESCHOOL; FEEDING BEHAVIOR; FEMALE; HUMANS; INSECT VECTORS; MALARIA; MALARIA VACCINES; MALE; MODELS, THEORETICAL;

EID: 84876151377     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-126     Document Type: Article

References (78)

1. World Health Organization, World Malaria Report 2010 WHO: Geneva: 2010
2. Effect of investment in malaria control on child mortality in sub-Saharan Africa in 2002-2008. Akachi Y, Atun R, PLoS ONE 2011 6 21309 10.1371/journal.pone.0021309 21738633
3. Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. Lim SS, Fullman N, Stokes A, Ravishankar N, Masiye F, Murray CJL, Gakidou E, PLoS Med 2011 8 1001091 10.1371/journal.pmed.1001091 21909249
4. The global distribution of clinical episodes of Plasmodium falciparum malaria. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, Nature 2005 434 214 217 10.1038/nature03342 15759000 (Pubitemid 40388051)
5. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
6. The public health impact of chloroquine resistance in Africa. Trape JF, Am J Trop Med Hyg 2001 64 1 Suppl 12 17 11425173
7. Insecticide resistance in insect vectors of human disease. Hemingway J, Ranson H, Annu Rev Entomol 2000 45 371 391 10.1146/annurev.ento.45.1.371 10761582 (Pubitemid 30187866)
8. Increased proportions of outdoor feeding among residual malaria vector populations following increased use of insecticide-treated nets in rural Tanzania. Russell TL, Govella NJ, Azizi S, Drakeley CJ, Kachur SP, Killeen GF, Malar J 2011 10 80 10.1186/1475-2875-10-80 21477321
9. The effect of a residual house-spraying campaign in East Africa on species balance in the Anopheles funestus group. The replacement of A. funestus Giles by A. rivulorum Leeson. Gillies MT, Smith A, Bull Entomol Res 1960 51 243 10.1017/S0007485300057953
10. Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Holder AA, Guevara Patiño JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ, Parassitologia 1999 41 409 414 10697894 (Pubitemid 129640287)
11. Molecular aspects of antigenic variation in Plasmodium falciparum. Horrocks P, Kyes SA, Bull PC, Deitsch KW, Molecular Approaches to Malaria Washington: ASM Press, Sherman IW, 2005 399 415
12. Antigenic variation in Plasmodium falciparum malaria involves a highly structured switching pattern. Recker M, Buckee CO, Serazin A, Kyes S, Pinches R, Christodoulou Z, Springer AL, Gupta S, Newbold CI, PLoS Pathog 2011 7 1001306 10.1371/journal.ppat.1001306 21408201
13. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nussenzweig RS, Vanderberg J, Most H, Orton C, Nature 1967 216 160 162 10.1038/216160a0 6057225
14. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Bojang KA, Milligan PJM, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WHH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KPWJ, Tornieporth N, Cohen JD, Doherty T, Lancet 2001 358 1927 1934 10.1016/S0140-6736(01)06957-4 11747915 (Pubitemid 34072872)
15. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitié MA, Dubovsky F, Menéndez C, Tornieporth N, Ballou WR, Thompson R, Cohen J, Lancet 2004 364 1411 1420 10.1016/S0140-6736(04)17223-1 15488216 (Pubitemid 39370716)
16. Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Aide P, Sigauque B, Milman J, Mandomando I, Bassat Q, Guinovart C, Espasa M, Corachan S, Lievens M, Navia MM, Dubois MC, Menéndez C, Dubovsky F, Cohen J, Thompson R, Ballou WR, Lancet 2005 366 2012 2018 10.1016/S0140-6736(05)67669-6 16338450 (Pubitemid 41773376)
17. Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age. Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu S, Lang T, Gould J, Dubois MC, Demoitié MA, Stallaert JF, Vansadia P, Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K, von Seidlein L, N Engl J Med 2008 359 2521 2532 10.1056/NEJMoa0807381 19064627
18. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. The RTS,S Clinical Trials Partnership, N Engl J Med 2011 365 1863 1875 22007715
19. The development of the RTS,S malaria vaccine candidate: challenges and lessons. Ballou WR, Parasite Immunol 2009 31 492 500 10.1111/j.1365-3024.2009. 01143.x 19691554
20. Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials. White MT, Griffin JT, Drakeley CJ, Ghani AC, Malar J 2010 9 82 10.1186/1475-2875-9-82 20331863
21. Modeling a field trial of the RTS,S/AS02A malaria vaccine. Maire N, Aponte JJ, Ross A, Thompson R, Alonso P, Utzinger J, Tanner M, Smith T, Am J Trop Med Hyg 2006 75 2 Suppl 104 110 16931821
22. Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Moorthy VS, Ballou WR, Malar J 2009 8 312 10.1186/1475-2875-8-312 20042088
23. Vaccines against malaria-an update. Matuschewski K, Mueller AK, FEBS Journal 2007 274 4680 4687 10.1111/j.1742-4658.2007.05998.x 17824954 (Pubitemid 47353123)
24. Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A, Vaccine 2005 23 3131 3138 10.1016/j.vaccine.2004.12.019 15837212
25. Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Kohama H, Tachibana M, Matsuzaki G, Torii M, Arakawa T, Infect Immun 2010 78 3773 3782 10.1128/IAI.00306-10 20584978
26. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with Montanide ISA 51. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP, PLoS ONE 2008 3 2636 10.1371/journal.pone.0002636 18612426
27. Ross R, The Prevention of Malaria New York: E.P. Dutton & Co.; 1910
28. Theory of the eradication of malaria. Macdonald G, Bull World Health Organ 1956 15 369 387 13404426
29. The Garki Project: research on the epidemiology and control of malaria in the Sudan savanna of West Africa. Molineaux L, Gramiccia G, World Health Organ, Geneva 1980
30. Modeling malaria vaccines I: new uses for old ideas. Struchiner CJ, Halloran ME, Spielman A, Math Biosci 1989 94 87 113 10.1016/0025-5564(89)90073-4 2520167 (Pubitemid 19131651)
31. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: overview. Smith T, Killeen G, Maire N, Ross A, Molineaux L, Tediosi F, Hutton G, Utzinger J, Dietz K, Tanner M, Am J Trop Med Hyg 2006 75 2 Suppl 1 10 17310537
32. A biologic basis for integrated malaria control. McKenzie FE, Baird JK, Beier JC, Lal AA, Bossert WH, Am J Trop Med Hyg 2002 67 571 577 12518846 (Pubitemid 36014912)
33. Revisiting the basic reproductive number for malaria and its implications for malaria control. Smith DL, McKenzie FE, Snow RW, Hay SI, PLoS Biol 2007 5 42 10.1371/journal.pbio.0050042 17311470 (Pubitemid 46422972)
34. What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines. Penny MA, Maire N, Studer A, Schapira A, Smith TA, PLoS ONE 2008 3 3193 10.1371/journal.pone.0003193 18784833
35. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, Bousema T, Drakeley CJ, Ferguson NM, Basáñez MG, Ghani AC, PLoS Med 2010 7 1000324 10.1371/journal. pmed.1000324 20711482
36. Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. Smith T, Ross A, Maire N, Chitnis N, Studer A, Hardy D, Brooks A, Penny M, Tanner M, PLoS Med 2012 9 1001157 10.1371/journal.pmed.1001157 22272189
37. A malaria transmission-directed model of mosquito life cycle and ecology. Eckhoff PA, Malar J 2011 10 303 10.1186/1475-2875-10-303 21999664
38. P. falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. Eckhoff P, PLoS ONE 2012 7 44950 10.1371/journal.pone.0044950 23028698
39. Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings. Eckhoff P, Am J Trop Med Hyg 2013 88 817 827 10.4269/ajtmh.12-0007 23589530
40. A global index representing the stability of malaria transmission. Kiszewski A, Mellinger A, Spielman A, Malaney P, Sachs SE, Sachs J, Am J Trop Med Hyg 2004 70 486 498 15155980 (Pubitemid 38658142)
41. A climate-based distribution model of malaria transmission in sub-Saharan Africa. Craig MH, Snow RW, le Sueur D, Parasitol Today 1999 15 105 111 10.1016/S0169-4758(99)01396-4 10322323 (Pubitemid 29341190)
42. Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Eckhoff PA, Malar J 2012 11 419 10.1186/1475-2875-11-419 23241282
43. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, Molineaux L, Am J Trop Med Hyg 2006 75 2 Suppl 19 31 16931812
44. Regulation of infectivity of Plasmodium to the mosquito vector. Sinden RE, Butcher GA, Billker O, Fleck SL, Adv Parasitol 1996 38 53 117 8701799 (Pubitemid 26289925)
45. Plasmodium falciparum gametocytes: their longevity and infectivity. Smalley ME, Sinden RE, Parasitology 1977 74 1 8 10.1017/S0031182000047478 320542 (Pubitemid 8016153)
46. Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Jeffery GM, Eyles DE, Am J Trop Med Hyg 1955 4 781 789 13259002
47. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, Sauerwein RW, Am J Trop Med Hyg 2007 76 470 474 17360869 (Pubitemid 351627738)
48. Cytokines kill malaria parasites during infection crisis: extracellular complementary factors are essential. Naotunne TS, Karunaweera ND, Del Giudice G Kularatne MU, J Exp Med 1991 173 523 529 10.1084/jem.173.3.523 1900073
49. Cytokine-mediated inactivation of malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates. Naotunne TS, Karunaweera ND, Mendis KN, Carter R, Immunology 1993 78 555 562 8495973 (Pubitemid 23114231)
50. The entomological inoculation rate and Plasmodium falciparum infection in African children. Smith DL, Dushoff J, Snow RW, Hay SI, Nature 2005 438 492 495 10.1038/nature04024 16306991 (Pubitemid 41742019)
51. Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission. Smith T, Charlwood JD, Kihonda J, Mwankusye S, Billingsley P, Meuwissen J, Lyimo E, Takken W, Teuscher T, Tanner M, Acta Trop 1993 54 55 72 10.1016/0001-706X(93)90068-M 8103627 (Pubitemid 23236067)
52. Full data reanalysis version 4. The Global Precipitation Climatology Centre, 2008 [ http://gpcc.dwd.de ]
53. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Beier JC, Killeen GF, Githure JI, Am J Trop Med Hyg 1999 61 109 113 10432066 (Pubitemid 29344998)
54. A new world malaria map: Plasmodium falciparum endemicity in 2010. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI, Malar J 2011 10 378 [ http://www.map.ox.ac.uk/browse-resources/ entomological-innoculation-rate/Pf-EIR/africa-plus/ ] 10.1186/1475-2875-10-378 22185615
55. Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. Killeen GF, Smith TA, Ferguson HM, Mshinda H, Abdulla S, Lengeler C, Kachur SP, PLoS Med 2007 4 229 10.1371/journal.pmed.0040229 17608562 (Pubitemid 47196227)
56. Trial of pyrethroid impregnated bednets in an area of Tanzania holoendemic for malaria. Part 2. Effects on the malaria vector population. Magesa SM, Wilkes TJ, Mnzava AE, Njunwa KJ, Myamba J, Kivuyo MD, Hill N, Lines JD, Curtis CF, Acta Trop 1991 49 97 108 10.1016/0001-706X(91)90057-Q 1680284
57. Influence of deltamethrin treatment of bed nets on malaria transmission in the Kou valley, Burkina Faso. Robert V, Carnevale P, Bull World Health Organ 1991 69 735 740 1786622
58. Insecticide-treated net (ITN) ownership, usage, and malaria transmission in the highlands of western Kenya. Atieli HE, Zhou G, Afrane Y, Lee MC, Mwanzo I, Githeko AK, Yan G, Parasit Vectors 2011 4 113 10.1186/1756-3305-4-113 21682919
59. Determinants of hanging and use of ITNs in the context of near universal coverage in Zambia. Macintyre K, Littrell M, Keating J, Hamainza B, Miller J, Eisele TP, Health Policy Plan 2012 27 316 325 10.1093/heapol/czr042 21652576
60. Assessment of insecticide-treated bednet use among children and pregnant women across 15 countries using standardized national surveys. Eisele TP, Keating J, Littrell M, Larsen D, Macintyre K, Am J Trop Med Hyg 2009 80 209 214 19190215
61. Human exposure to anopheline mosquitoes occurs primarily indoors, even for users of insecticide-treated nets in Luangwa Valley, South-east Zambia. Seyoum A, Sikaala CH, Chanda J, Chinula D, Ntamatungiro AJ, Hawela M, Miller JM, Russell TL, Briët OJT, Killeen GF, Parasit Vectors 2012 5 101 10.1186/1756-3305-5-101 22647493
62. Consistently high estimates for the proportion of human exposure to malaria vector populations occurring indoors in rural Africa. Huho B, Briët O, Seyoum A, Sikaala C, Bayoh N, Gimnig J, Okumu F, Diallo D, Abdulla S, Smith TA, Killeen GF, Int J Epidemiol 2013 42 235 247 10.1093/ije/dys214 23396849
63. Spatial distribution of bednet coverage under routine distribution through the public health sector in a rural district in Kenya. O'Meara WP, Smith N, Ekal E, Cole D, Ndege S, PLoS ONE 2011 6 25949 10.1371/journal.pone.0025949 22022481
64. Travel risk, malaria importation and malaria transmission in Zanzibar. Le Menach A, Tatem AJ, Cohen JM, Hay SI, Randell H, Patil AP, Smith DL, Sci Rep 2011 1 93 22355611
65. Quantifying the impact of human mobility on malaria. Wesolowski A, Eagle N, Tatem AJ, Smith DL, Noor AM, Snow RW, Buckee CO, Science 2012 338 267 70 10.1126/science.1223467 23066082
66. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Snow RW, Craig M, Deichmann U, Marsh K, Bull World Health Organ 1999 77 624 640 10516785 (Pubitemid 29446615)
67. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K, Nat Med 1998 4 358 360 10.1038/nm0398-358 9500614 (Pubitemid 28144099)
68. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GAT, Trends Parasitol 2006 22 424 430 10.1016/j.pt.2006.07.001 16846756 (Pubitemid 44176410)
69. Stable and unstable malaria hotspots in longitudinal cohort studies in Kenya. Bejon P, Williams TN, Liljander A, Noor AM, Wambua J, Ogada E, Olotu A, Osier FHA, Hay SI, Färnert A, Marsh K, PLoS Med 2010 7 1000304 10.1371/journal.pmed.1000304 20625549
70. Hitting hotspots: spatial targeting of malaria for control and elimination. Bousema T, Griffin JT, Sauerwein RW, Smith DL, Churcher TS, Takken W, Ghani A, Drakeley C, Gosling R, PLoS Med 2012 9 1001165 10.1371/journal.pmed. 1001165 22303287
71. Simulation of the cost-effectiveness of malaria vaccines. Tediosi F, Maire N, Penny M, Studer A, Smith TA, Malar J 2009 8 127 10.1186/1475-2875-8-127 19505328
72. Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data. Bejon P, White MT, Olotu A, Bojang K, Lusingu JPA, Salim N, Otsyula NN, Agnandji ST, Asante KP, Owusu-Agyei S, Abdulla S, Ghani AC, Lancet Infect Dis 2013 13 319 327 10.1016/S1473-3099(13)70005-7 23454164
73. Feachem RGA, Phillips AA, Targett GA, Shrinking the Malaria Map: a Prospectus on Malaria Elimination San Francisco: The Global Health Group: UCSF Global Health Sciences 2009
74. Barriers to insecticide-treated mosquito net possession 2 Years after a mass free distribution campaign in Luangwa District, Zambia. Larsen DA, Keating J, Miller J, Bennett A, Changufu C, Katebe C, Eisele TP, PLoS ONE 2010 5 13129 10.1371/journal.pone.0013129 21085711
75. Sustained high coverage of insecticide-treated bednets through combined Catch-up and Keep-up strategies. Grabowsky M, Nobiya T, Selanikio J, Trop Med Int Health 2007 12 815 822 10.1111/j.1365-3156.2007.01862.x 17596247 (Pubitemid 46998289)
76. Viewpoint: a framework for decision-making in integrated vector management to prevent disease. Van Den Berg H, Takken W, Trop Med Int Health 2007 12 1230 1238 10.1111/j.1365-3156.2007.01905.x 17956506 (Pubitemid 47621999)
77. The potential impact of integrated malaria transmission control on entomologic inoculation rate in highly endemic areas. Killeen GF, McKenzie FE, Foy BD, Schieffelin C, Billingsley PF, Beier JC, Am J Trop Med Hyg 2000 62 545 551 11289662 (Pubitemid 32210473)
78. Integrated urban malaria control: a case study in Dar es Salaam, Tanzania. Caldas de Castro M, Yamagata Y, Mtasiwa D, Tanner M, Utzinger J, Keiser J, Singer BH, Am J Trop Med Hyg 2004 71 2 Suppl 103 117 15331826 (Pubitemid 39121311)